WFDC2 and Miyoshi myopathy: For MM-ASCT vs controls, the combination of following analyte pairs resulted in 100% correct separation: sBAFF-GDF15 (Figure 6E) or sBAFF in combination with other analytes such as CSF1, sTGFA, TRAP, sTNFR2, sTNFRSF4 or HE4.